G.L. Pharma Nordic Aktiebolag: vundne offentlige udbud

Ifølge tildelingsbekendtgørelser i TED har G.L. Pharma Nordic Aktiebolag vundet 8 udbud hos danske ordregivere med en samlet oplyst værdi på 955.703.492 kr.. Den seneste tildeling er dateret 25. oktober 2026.

UdbudOrdregiverVindereVærdiDato
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 1.603.aAmgros I/SG.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS148.245.484 kr.21. oktober 2026
Amgros 2027 1.603.aAmgros I/SG.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS148.245.484 kr.21. oktober 2026
Amgros 2027 1.603.aAmgros I/SG.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS148.245.484 kr.21. oktober 2026

Datakilde: TED © Den Europæiske Union. Tildelingsbekendtgørelser fra danske ordregivere.

Vinderbadge til din hjemmeside

Repræsenterer du G.L. Pharma Nordic Aktiebolag? Kopiér koden og indsæt den på jeres hjemmeside. Badget linker til denne side.

Forhåndsvisning:

🏆 G.L. Pharma Nordic Aktiebolag har vundet offentlige udbud – se udbuddene på EU-udbud.dk